Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Daniel Edwin Singer, M.D.

Co-Author

This page shows the publications co-authored by Daniel Singer and James Meigs.
Connection Strength

1.701
  1. Metabolic risk factors worsen continuously across the spectrum of nondiabetic glucose tolerance. The Framingham Offspring Study. Ann Intern Med. 1998 Apr 01; 128(7):524-33.
    View in: PubMed
    Score: 0.189
  2. Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study. Diabetes. 1997 Oct; 46(10):1594-600.
    View in: PubMed
    Score: 0.182
  3. Tracking of glycated hemoglobin in the original cohort of the Framingham Heart Study. J Clin Epidemiol. 1996 Apr; 49(4):411-7.
    View in: PubMed
    Score: 0.164
  4. Frequent outpatient contact and decreasing medication affordability in patients with diabetes from 1997 to 2004. Diabetes Care. 2006 Jun; 29(6):1386-8.
    View in: PubMed
    Score: 0.083
  5. Medication adherence before an increase in antihypertensive therapy: a cohort study using pharmacy claims data. Clin Ther. 2005 Jun; 27(6):773-81.
    View in: PubMed
    Score: 0.077
  6. Impact of concurrent medication use on statin adherence and refill persistence. Arch Intern Med. 2004 Nov 22; 164(21):2343-8.
    View in: PubMed
    Score: 0.075
  7. A controlled trial of population management: diabetes mellitus: putting evidence into practice (DM-PEP). Diabetes Care. 2004 Oct; 27(10):2299-305.
    View in: PubMed
    Score: 0.074
  8. Trends in complexity of diabetes care in the United States from 1991 to 2000. Arch Intern Med. 2004 May 24; 164(10):1134-9.
    View in: PubMed
    Score: 0.072
  9. Clinical inertia in the management of Type 2 diabetes metabolic risk factors. Diabet Med. 2004 Feb; 21(2):150-5.
    View in: PubMed
    Score: 0.071
  10. Health care resource utilization associated with a diabetes center and a general medicine clinic. J Gen Intern Med. 2004 Jan; 19(1):28-35.
    View in: PubMed
    Score: 0.070
  11. Improving adherence and reducing medication discrepancies in patients with diabetes. Ann Pharmacother. 2003 Jul-Aug; 37(7-8):962-9.
    View in: PubMed
    Score: 0.068
  12. Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care. 2003 May; 26(5):1408-12.
    View in: PubMed
    Score: 0.067
  13. A controlled trial of web-based diabetes disease management: the MGH diabetes primary care improvement project. Diabetes Care. 2003 Mar; 26(3):750-7.
    View in: PubMed
    Score: 0.066
  14. Tests of glycemia for the diagnosis of type 2 diabetes mellitus. Ann Intern Med. 2002 Aug 20; 137(4):263-72.
    View in: PubMed
    Score: 0.064
  15. Comparison of hyperglycemia, hypertension, and hypercholesterolemia management in patients with type 2 diabetes. Am J Med. 2002 Jun 01; 112(8):603-9.
    View in: PubMed
    Score: 0.063
  16. The effect of interventions to prevent cardiovascular disease in patients with type 2 diabetes mellitus. Am J Med. 2001 Dec 01; 111(8):633-42.
    View in: PubMed
    Score: 0.061
  17. Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study. Diabetes Care. 2001 Aug; 24(8):1403-10.
    View in: PubMed
    Score: 0.059
  18. Apolipoprotein E isoform polymorphisms are not associated with insulin resistance: the Framingham Offspring Study. Diabetes Care. 2000 May; 23(5):669-74.
    View in: PubMed
    Score: 0.054
  19. Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study. JAMA. 2000 Jan 12; 283(2):221-8.
    View in: PubMed
    Score: 0.053
  20. The epidemiology of cardiovascular disease in type 2 diabetes mellitus: how sweet it is ... or is it? Lancet. 1997 Jul; 350 Suppl 1:SI4-9.
    View in: PubMed
    Score: 0.045
  21. Metabolic control and prevalent cardiovascular disease in non-insulin-dependent diabetes mellitus (NIDDM): The NIDDM Patient Outcome Research Team. Am J Med. 1997 Jan; 102(1):38-47.
    View in: PubMed
    Score: 0.043
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.